{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T14:28:36Z","timestamp":1770906516660,"version":"3.50.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T00:00:00Z","timestamp":1483920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T00:00:00Z","timestamp":1483920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1038\/bmt.2016.301","type":"journal-article","created":{"date-parts":[[2017,1,9]],"date-time":"2017-01-09T15:06:22Z","timestamp":1483974382000},"page":"570-573","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Dose-adapted post-transplant cyclophosphamide for HLA-haploidentical transplantation in Fanconi anemia"],"prefix":"10.1038","volume":"52","author":[{"given":"M S","family":"Thakar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Bonfim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M C","family":"Walters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Storb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Pasquini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L","family":"Burroughs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B M","family":"Sandmaier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A","family":"Woolfrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H-P","family":"Kiem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,1,9]]},"reference":[{"key":"BFbmt2016301_CR1","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1002\/ajmg.a.34087","volume":"155a","author":"PS Rosenberg","year":"2011","unstructured":"Rosenberg PS, Tamary H, Alter BP . How high are carrier frequencies of rare recessive syndromes? Contemporary estimates for Fanconi Anemia in the United States and Israel. Am J Med Genet A 2011; 155a: 1877\u20131883.","journal-title":"Am J Med Genet A"},{"key":"BFbmt2016301_CR2","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.bbmt.2007.08.004","volume":"13","author":"CM Bonfim","year":"2007","unstructured":"Bonfim CM, de Medeiros CR, Bitencourt MA, Zanis-Neto J, Funke VA, Setubal DC et al. HLA-matched related donor hematopoietic cell transplantation in 43 patients with fanconi anemia conditioned with 60\u2009mg\/kg of cyclophosphamide. Biol Blood Marrow Transplant 2007; 13: 1455\u20131460.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016301_CR3","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1182\/blood-2006-07-036657","volume":"109","author":"JE Wagner","year":"2007","unstructured":"Wagner JE, Eapen M, MacMillan ML, Harris RE, Pasquini R, Boulad F et al. Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. Blood 2007; 109: 2256\u20132262.","journal-title":"Blood"},{"key":"BFbmt2016301_CR4","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.bbmt.2014.01.015","volume":"20","author":"M Zecca","year":"2014","unstructured":"Zecca M, Strocchio L, Pagliara D, Comoli P, Bertaina A, Giorgiani G et al. HLA-haploidentical T cell-depleted allogeneic hematopoietic stem cell transplantation in children with Fanconi anemia. Biol Blood Marrow Transplant 2014; 20: 571\u2013576.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016301_CR5","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","volume":"14","author":"L Luznik","year":"2008","unstructured":"Luznik L, O'Donnell PV, Symons HJ, Chen AR, Leffell MS, Zahurak M et al. HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, post-transplantation cyclophosphamide. Biol Blood Marrow Transplant 2008; 14: 641\u2013650.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016301_CR6","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/bmt.2008.203","volume":"42","author":"RA Brodsky","year":"2008","unstructured":"Brodsky RA, Luznik L, Bolanos-Meade J, Leffell MS, Jones RJ, Fuchs EJ . Reduced intensity HLA-haploidentical BMT with post transplantation cyclophosphamide in nonmalignant hematologic diseases. Bone Marrow Transplant 2008; 42: 523\u2013527.","journal-title":"Bone Marrow Transplant"},{"key":"BFbmt2016301_CR7","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1111\/j.1365-2141.1980.tb07179.x","volume":"45","author":"R Berger","year":"1980","unstructured":"Berger R, Bernheim A, Gluckman E, Gisselbrecht C . In vitro effect of cyclophosphamide metabolites on chromosomes of Fanconi anaemia patients. Br J Haematol 1980; 45: 565\u2013568.","journal-title":"Br J Haematol"},{"key":"BFbmt2016301_CR8","doi-asserted-by":"publisher","first-page":"568","DOI":"10.3109\/08880018.2012.708708","volume":"29","author":"MS Thakar","year":"2012","unstructured":"Thakar MS, Bonfim C, Sandmaier BM, O'Donnell P, Ribeiro L, Gooley T et al. Cyclophosphamide-based in vivo T-cell depletion for HLA-haploidentical transplantation in Fanconi anemia. Pediatr Hematol Oncol 2012; 29: 568\u2013578.","journal-title":"Pediatr Hematol Oncol"},{"key":"BFbmt2016301_CR9","doi-asserted-by":"publisher","first-page":"3390","DOI":"10.1182\/blood.V97.11.3390","volume":"97","author":"PA McSweeney","year":"2001","unstructured":"McSweeney PA, Niederwieser D, Shizuru JA, Sandmaier BM, Molina AJ, Maloney DG et al. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 2001; 97: 3390\u20133400.","journal-title":"Blood"},{"key":"BFbmt2016301_CR10","doi-asserted-by":"publisher","first-page":"2021","DOI":"10.1182\/blood-2003-02-0482","volume":"102","author":"MB Maris","year":"2003","unstructured":"Maris MB, Niederwieser D, Sandmaier BM, Storer B, Stuart M, Maloney D et al. HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies. Blood 2003; 102: 2021\u20132030.","journal-title":"Blood"},{"key":"BFbmt2016301_CR11","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1053\/bbmt.2002.v8.pm12171484","volume":"8","author":"PV O'Donnell","year":"2002","unstructured":"O'Donnell PV, Luznik L, Jones RJ, Vogelsang GB, Leffell MS, Phelps M et al. Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide. Biol Blood Marrow Transplant 2002; 8: 377\u2013386.","journal-title":"Biol Blood Marrow Transplant"},{"key":"BFbmt2016301_CR12","doi-asserted-by":"publisher","first-page":"3224","DOI":"10.1182\/blood-2009-11-251595","volume":"115","author":"L Luznik","year":"2010","unstructured":"Luznik L, Bolanos-Meade J, Zahurak M, Chen AR, Smith BD, Brodsky R et al. High-dose cyclophosphamide as single-agent, short-course prophylaxis of graft-versus-host disease. Blood 2010; 115: 3224\u20133230.","journal-title":"Blood"},{"key":"BFbmt2016301_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1365-2141.2005.05549.x","volume":"130","author":"J Zanis-Neto","year":"2005","unstructured":"Zanis-Neto J, Flowers MED, Medeiros CR, Bitencourt MA, Bonfim CM, Set\u00fabal DC et al. Low-dose cyclophosphamide conditioning for haematopoietic cell transplantation from HLA-matched related donors in patients with Fanconi anemia. Br J Haematol 2005; 130: 99\u2013106.","journal-title":"Br J Haematol"},{"key":"BFbmt2016301_CR14","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00007890-197410000-00001","volume":"18","author":"H Glucksberg","year":"1974","unstructured":"Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295\u2013304.","journal-title":"Transplantation"},{"key":"BFbmt2016301_CR15","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1399-0012.1987.tb00685.x","volume":"1","author":"GW Santos","year":"1987","unstructured":"Santos GW, Tutschka PJ, Brookmeyer R, Saral R, Beschorner WE, Bias WB et al. Cyclosporine plus methylprednisolone versus cyclophosphamide plus methylprednisolone as prophylaxis for graft-versus-host disease: a randomized double-blind study in patients undergoing allogeneic marrow transplantation. Clin Transplant 1987; 1: 21\u201328.","journal-title":"Clin Transplant"},{"key":"BFbmt2016301_CR16","doi-asserted-by":"publisher","first-page":"3798","DOI":"10.1182\/blood-2015-02-626002","volume":"125","author":"ML MacMillan","year":"2015","unstructured":"MacMillan ML, DeFor TE, Young JA, Dusenbery KE, Blazar BR, Slungaard A et al. Alternative donor hematopoietic cell transplantation for Fanconi anemia. Blood 2015; 125: 3798\u20133804.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/bmt2016301.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2016301","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/bmt2016301.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T04:03:14Z","timestamp":1749873794000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/bmt2016301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,9]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["BFbmt2016301"],"URL":"https:\/\/doi.org\/10.1038\/bmt.2016.301","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,9]]},"assertion":[{"value":"18 May 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2016","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 August 2016","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2017","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}